Gland Pharma has appointed Shyamakant Giri as its new CEO, effective January 15, 2025. Giri currently serves as President of Amneal Pharmaceuticals.
New Delhi, Oct 18 (PTI) Gland Pharma on Friday said its board has appointed Shyamakant Giri as CEO with effect from January 15, 2025.
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals, responsible for the commercial expansion and growth in India and Rest of the World markets.
Srinivas Sadu will continue to be the executive chairman of the company and support its next phase of growth, Gland Pharma said.
Home » Market News » Gland Pharma Appoints Shyamakant Giri as CEO
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback